Mnk
mnk.comRank Trend
Ranking history over time.
About Mnk
Mallinckrodt and Endo have merged to form a global therapeutics company focused on providing branded and generic pharmaceutical products. The site introduces their new entities, Keenova and Par Health, which aim to address various medical conditions and provide essential healthcare solutions.
Explore innovative healthcare solutions for patients with unique medical needs.
What You Can Do
- Learn about Keenova's focus on rare conditions
- Discover Par Health's generics and injectables
- Access company updates and news
Frequently Asked Questions
What is the purpose of the merger between Mallinckrodt and Endo?
The merger aims to create a leading global therapeutics company to better serve patients and customers.
What does Keenova specialize in?
Keenova focuses on helping patients with rare, stigmatized, or unaddressed conditions across various medical fields.
What products does Par Health offer?
Par Health develops high-quality generics, sterile injectables, and active pharmaceutical ingredients.
How can I contact the company?
You can contact the company at 1-800-462-ENDO (3636) for inquiries.
Are Keenova and Par Health the same company?
No, they operate as separate companies with distinct missions and identities.